Companies /Industrials

BWX Technologies Inc

NYSE: BWXT Aerospace & Defense
$158.78
â–² $6.49 (+4.26%) today
Markets open · 2:01pm ET

Q3 2025 Earnings

Reported Nov 3, 2025, 4:19pm ET · SEC source
$1.00
Beat +16.55%
EPS · est. $0.86
$866.3M
Beat +8.75%
Revenue · est. $796.6M
−12.8%
Trailing market
BWXT vs S&P since report
6 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−8%−4%0Nov 3Nov 4report 4:19pm ETearnings−1.6%−9.6%
−8%−4%0Nov 3Nov 4earnings−1.6%−9.6%
BWXT −9.6%S&P 500 −1.6%
−8%−4%0Nov 3Nov 4report 4:19pm ETearnings−2.7%−9.6%
−8%−4%0Nov 3Nov 4earnings−2.7%−9.6%
BWXT −9.6%NASDAQ −2.7%
−8%−4%0+4%Nov 3Nov 11report 4:19pm ETearnings−0.0%−5.9%
−8%−4%0+4%Nov 3Nov 11earnings−0.0%−5.9%
BWXT −5.9%S&P 500 −0.0%
−8%−4%0+4%Nov 3Nov 11report 4:19pm ETearnings−1.6%−5.9%
−8%−4%0+4%Nov 3Nov 11earnings−1.6%−5.9%
BWXT −5.9%NASDAQ −1.6%
−7.17%
Day of report
−1.13%
Next session
−2.37%
One week
−11.24%
30 days

S&P 500 over the same 30 days: +1.55%.

Did BWXT Beat Earnings? Q3 2025 Results

BWX Technologies turned in a standout third quarter for fiscal 2025, posting earnings per share of $1.00 against a consensus estimate of $0.858 — a beat of 16.55% — while revenue surged 28.9% year-over-year to $866.29 million, clearing Wall Street's $796.60 million estimate by 8.75%. The outperformance was anchored by an explosive quarter in Commercial Operations, where revenue more than doubled to $251.00 million on higher nuclear components, field services, and contributions from the Kinectrics acquisition, complementing steady 10% growth in the core Government Operations segment. Perhaps the most striking figure was BWXT's record backlog of $7.39 billion, up 119% year-over-year, a reflection of what management called an unprecedented demand environment across defense, clean energy, and medical nuclear markets. Free cash flow swung to $94.90 million from negative $7.70 million a year ago, adding financial credibility to the growth story. Encouraged by the momentum, management raised its 2025 non-GAAP EPS guidance to $3.75–$3.80 and set full-year revenue above $3.10 billion, while introducing a preliminary 2026 outlook targeting low-double-digit to low-teens adjusted EBITDA growth.

Key Takeaways
  • Higher naval nuclear component production volumes
  • Special materials processing growth with large multi-year contracts
  • Contribution from A.O.T. and Kinectrics acquisitions
  • Higher commercial nuclear components, field services, and fuel handling revenue
  • Higher medical sales
  • Strong working capital management and timing of awards driving cash flow improvement
  • Record backlog of $7.4 billion, up 119% YoY

“We delivered strong financial results in the third quarter of 2025 including double-digit organic revenue growth and healthy free cash flow. Further, we posted another quarter of robust bookings, driven by large, multi-year special materials contracts highlighting the trust our customers put in BWXT and the power in our differentiating nuclear credentials.”

BWX Technologies CEO, on the earnings call

Forward Guidance & Outlook

BWXT raised its 2025 guidance: revenue now expected above $3.1 billion (up from ~$3.1 billion), non-GAAP EPS guidance raised to $3.75-$3.80 (from $3.65-$3.75), adjusted EBITDA narrowed to ~$570 million (mid-point of prior $565-$575 million range), and free cash flow raised to ~$285 million (from $275-$285 million range). The company introduced a preliminary 2026 outlook calling for low-double-digit to low-teens adjusted EBITDA growth and high-single-digit to low-double-digit non-GAAP EPS growth, positioning BWXT to meet or exceed its medium-term financial targets.

BWXT YoY Financials

Q3 2025 vs Q3 2024 · SEC filings Q3 2024 Q3 2025
$0$300.0M$600.0M$900.0M$672.0M$866.3MRevenue$164.0M$189.0MGross Profit$96.6M$113.3MOperating Income$69.5M$82.2MNet Income
$0$300.0M$600.0M$900.0MRevenueGross ProfitOperating IncomeNet Income

BWXT Revenue by Segment

Government Operations$616.7M+10.0%
Commercial Operations$251.0M+122.0%

Figures from SEC filings and company reports. Not investment advice.